Clinical Spectrum of Noonan Syndrome–Associated Myeloproliferative Disorder
Shinsuke Hirabayashi(Hokkaido University), Hideki Muramatsu(Nagoya University), Kazuo Sakashita(Nagano Children's Hospital), Manabu Wakamatsu(Nagoya University), Makiko Mori(Morioka University), Nao Yoshida(Nihon University), Yoko Aoki(Tohoku University), Yoko Mizoguchi(Hiroshima University), Kaori Fujiwara(Okayama University Hospital), Shoji Saito(Shinshu University), Takahiro Imaizumi(Kurume University), Shuichi Ozono(Fukuoka University), Kyogo Suzuki(Saitama Children's Medical Center), Mizuka Miki(Hiroshima City Asa Citizens Hospital), Yuko Honda(University of Occupational and Environmental Health Japan), Hiroyoshi Watanabe(Tokushima University), Masataka Hasegawa(Hokkaido University)
Cited by 0
Related Papers
Erratum: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)
|Hypertension Research|2014|1.4k
<i>HRAS</i> mutation analysis in Costello syndrome: Genotype and phenotype correlation
|American Journal of Medical Genetics Part A|2005|189
Two Aldehyde Clearance Systems Are Essential to Prevent Lethal Formaldehyde Accumulation in Mice and Humans
|Molecular Cell|2020|189
LZTR1 facilitates polyubiquitination and degradation of RAS-GTPases
|Cell Death and Differentiation|2019|127